Literature DB >> 9392842

Endomorphin 1 and 2, endogenous ligands for the mu-opioid receptor, decrease cardiac output, and total peripheral resistance in the rat.

H C Champion1, J E Zadina, A J Kastin, L Hackler, L J Ge, P J Kadowitz.   

Abstract

Endomorphin 1 and 2 are recently discovered endogenous ligands for the mu-opioid receptor. In the present study, responses to intravenous administration of endomorphin 1 and 2 were investigated in the systemic vascular bed of the rat. Endomorphin 1 and 2 induced dose-related decreases in systemic arterial pressure when injected in doses of 10-100 nmol/kg i.v.. The decreases in systemic arterial pressure in response to endomorphin 1 and 2 were associated with significant decreases in heart rate, cardiac output, and total peripheral resistance. The endogenous ligand for the ORL1 receptor, nociceptin/OFQ had similar effects on systemic arterial pressure, heart rate, cardiac output, and total peripheral resistance in the rat. Injections of isoproterenol (1 microgram/kg i.v.) and calcitonin gene-related peptide (CGRP; 0.3 nmol/kg i.v.), decreased systemic arterial pressure and total peripheral resistance. However these decreases in arterial pressure were associated with increases in heart rate and cardiac output. The results of the present study demonstrate that the endomorphin peptides have significant vasodilator activity in the systemic vascular bed of the rat and show that this response is associated with a decrease in heart rate and cardiac output.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9392842     DOI: 10.1016/s0196-9781(97)00210-6

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  11 in total

1.  Effects of nociceptin and nocistatin on antidromic vasodilatation in hairless skin of the rat hindlimb in vivo.

Authors:  H Häbler; L Timmermann; J Stegmann; W Jänig
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

Review 2.  Engineering endomorphin drugs: state of the art.

Authors:  Lawrence H Lazarus; Yoshio Okada
Journal:  Expert Opin Ther Pat       Date:  2012-01-04       Impact factor: 6.674

3.  Effects of endomorphin-1 on open-field behavior and on the hypothalamic-pituitary-adrenal system.

Authors:  E Bujdosó; M Jászberényi; C Tömböly; G Tóth; G Telegdy
Journal:  Endocrine       Date:  2001-03       Impact factor: 3.633

4.  Endomorphin-1 induced desensitization and down-regulation of the recombinant mu-opioid receptor.

Authors:  C Harrison; D J Rowbotham; D K Grandy; D G Lambert
Journal:  Br J Pharmacol       Date:  2000-11       Impact factor: 8.739

5.  The effects of endomorphin-1 and endomorphin-2 in CHO cells expressing recombinant mu-opioid receptors and SH-SY5Y cells.

Authors:  C Harrison; S McNulty; D Smart; D J Rowbotham; D K Grandy; L A Devi; D G Lambert
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

6.  Effects of nociceptin/orphanin FQ receptor ligands on blood pressure, heart rate, and plasma catecholamine concentrations in guinea pigs.

Authors:  Eiji Hashiba; Kazuyoshi Hirota; Tsuyoshi Kudo; Girolamo Calo'; Remo Guerrini; Akitomo Matsuki
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-03-08       Impact factor: 3.000

7.  Endomorphin-2 is released from newborn rat primary sensory neurons in a frequency- and calcium-dependent manner.

Authors:  Heather L Scanlin; Elizabeth A Carroll; Victoria K Jenkins; Agnieszka Balkowiec
Journal:  Eur J Neurosci       Date:  2008-05-29       Impact factor: 3.386

8.  Endomorphin 1 and endomorphin 2 suppress in vitro antibody formation at ultra-low concentrations: anti-peptide antibodies but not opioid antagonists block the activity.

Authors:  Benito Anton; Phillipe Leff; Juan C Calva; Rodolfo Acevedo; Alberto Salazar; Maura Matus; Lenin Pavón; Martin Martinez; Joseph J Meissler; Martin W Adler; John P Gaughan; Toby K Eisenstein
Journal:  Brain Behav Immun       Date:  2008-04-18       Impact factor: 7.217

9.  Use of preproenkephalin knockout mice and selective inhibitors of enkephalinases to investigate the role of enkephalins in various behaviours.

Authors:  Florence Noble; Nadia Benturquia; Andras Bilkei-Gorzo; Andreas Zimmer; Bernard P Roques
Journal:  Psychopharmacology (Berl)       Date:  2007-10-01       Impact factor: 4.530

10.  Decreased Endomorphin-2 and μ-Opioid Receptor in the Spinal Cord Are Associated with Painful Diabetic Neuropathy.

Authors:  Zhen-Zhen Kou; Fa-Ping Wan; Yang Bai; Chun-Yu Li; Jia-Chen Hu; Guo-Tao Zhang; Ting Zhang; Tao Chen; Ya-Yun Wang; Hui Li; Yun-Qing Li
Journal:  Front Mol Neurosci       Date:  2016-09-07       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.